Precision medicine - Delivering the goods?

Cancer Letters

Volumn 352, Issue 1, 2014, Pages 2-3

  Peer, Dan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

NanoMedicines; OMICS; Personalized oncology; Precision medicine

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; LONG UNTRANSLATED RNA;

BREAST CANCER; CANCER IMMUNOTHERAPY; CELL THERAPY; CHILDHOOD LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CIRCULATING TUMOR CELL; COLORECTAL CANCER; GENOMICS; HUMAN; METABOLOMICS; METASTASIS; NANOMEDICINE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROTEOMICS; SHORT SURVEY; T CELL THERAPY; TUMOR MICROENVIRONMENT;

NANOMEDICINES; OMICS; PERSONALIZED ONCOLOGY; PRECISION MEDICINE;

HUMANS; INDIVIDUALIZED MEDICINE; NANOMEDICINE; NEOPLASMS;

EID: 84906049804     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.04.011     Document Type: Review

References (14)

1. Rozovski U., Hazan-Halevy I., Keating M.J., Estrov Z. Personalized medicine in CLL: current status and future perspectives. Cancer Lett. 2013.
2. Izraeli S., Shochat C., Tal N., Geron I. Towards precision medicine in childhood leukemia - insights from mutationally activated cytokine receptor pathways in acute lymphoblastic leukemia. Cancer Lett. 2014.
3. Raanani P., Granot G., Ben-Bassat I. Is cure of chronic myeloid leukemia in the third millennium a down to earth target (ed) or a castle in the air?. Cancer Lett. 2014.
4. Kraus S., Nabiochtchikov I., Shapira S., Arber N. Recent advances in personalized colorectal cancer research. Cancer Lett. 2014, 347:15-21.
5. Hughes A.D., Marshall J.R., Keller E., Powderly J.D., Greene B.T., King M.R. Differential drug responses of circulating tumor cells within patient blood. Cancer Lett. 2013.
6. Sharifzadeh Z., Rahbarizadeh F., Shokrgozar M.A., et al. Genetically engineered T cells bearing chimeric nanoconstructed receptors harboring TAG-72-specific camelid single domain antibodies as targeting agents. Cancer Lett. 2013, 334:237-244.
7. Weitzenfeld P., Ben-Baruch A. The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer. Cancer Lett. 2013.
8. Klein-Goldberg A., Maman S., Witz I.P. The role played by the microenvironment in site-specific metastasis. Cancer Lett. 2013.
9. Canaani D. Application of the concept synthetic lethality toward anticancer therapy: a promise fulfilled?. Cancer Lett. 2013.
10. Ballarin-Gonzalez B., Ebbesen M.F., Howard K.A. Polycation-based nanoparticles for RNAi-mediated cancer treatment. Cancer Lett. 2013.
11. Ferber S., Baabur-Cohen H., Blau R., et al. Polymeric nanotheranostics for real-time non-invasive optical imaging of breast cancer progression and drug release. Cancer Lett. 2014.
12. Padler-Karavani V. Aiming at the sweet side of cancer: aberrant glycosylation as possible target for personalized-medicine. Cancer Lett. 2013.
13. Wayteck L., Breckpot K., Demeester J., De Smedt S.C., Raemdonck K. A personalized view on cancer immunotherapy. Cancer Lett. 2013.
14. Rosenblum D., Peer D. Omics-based nanomedicine: the future of personalized oncology. Cancer Lett. 2013.